Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers

BACKGROUND: The issue of overdiagnosis in low-dose computed tomography (LDCT) screening trials could be addressed by the development of complementary bio-markers able to improve detection of aggressive disease. The mutation profile of LDCT screening–detected lung tumors is currently unknown. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Verri, Carla, Borzi, Cristina, Holscher, Todd, Dugo, Matteo, Devecchi, Andrea, Drake, Katherine, Sestini, Stefano, Suatoni, Paola, Romeo, Elisa, Sozzi, Gabriella, Pastorino, Ugo, Boeri, Mattia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832691/
https://www.ncbi.nlm.nih.gov/pubmed/28302568
http://dx.doi.org/10.1016/j.jtho.2017.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832691/
https://www.ncbi.nlm.nih.gov/pubmed/28302568
http://dx.doi.org/10.1016/j.jtho.2017.03.001

Ejemplares similares